[go: up one dir, main page]

SV1997000026A - Composiciones farmaceuticas para el tratamiento de la rinitis - Google Patents

Composiciones farmaceuticas para el tratamiento de la rinitis

Info

Publication number
SV1997000026A
SV1997000026A SV1997000026A SV1997000026A SV1997000026A SV 1997000026 A SV1997000026 A SV 1997000026A SV 1997000026 A SV1997000026 A SV 1997000026A SV 1997000026 A SV1997000026 A SV 1997000026A SV 1997000026 A SV1997000026 A SV 1997000026A
Authority
SV
El Salvador
Prior art keywords
rhinitis
treatment
pharmaceutical compositions
selected compound
pseudoefedrine
Prior art date
Application number
SV1997000026A
Other languages
English (en)
Inventor
De Venne Herman Van
Jean-Pierre Martin
Original Assignee
Ucb Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24521774&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SV1997000026(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ucb Sa filed Critical Ucb Sa
Publication of SV1997000026A publication Critical patent/SV1997000026A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

EL INVENTO SE RELACIONA CON UNA COMPOSICION FARMACEUTICA QUE COMPRENDE UNA CANTIDAD TERAPEUTICAMENTE EFICAZ DE UNA MEZCLA CONSISTENTE ESENCIALMENTE POR: (i) COMPUESTO SELECCIONADO DE PSEUDOEFEDRINA, FENILPROPANOLAMINA Y FENILEFRINA, UN ISOMERO OPTICO INDIVIDUAL O UNA SAL FARMACEUTICAMENTE ACEPTABLE DE LA MISMA; (ii) AL MENOS UN COMPUESTO SELECCIONADO DEL ACIDO 2-[4-(DIFENILMETIL)-1-PIPERACINIL]-ACETICO O DERIVADO AMIDICO, UN ISOMERO OPTICO INDIVIDUAL O UNA SAL FARACEUTICAMENTE ACEPTABLE DEL MISMO.
SV1997000026A 1996-04-08 1997-04-08 Composiciones farmaceuticas para el tratamiento de la rinitis SV1997000026A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/629,144 US6469009B1 (en) 1996-04-08 1996-04-08 Pharmaceutical compositions for the treatment of rhinitis

Publications (1)

Publication Number Publication Date
SV1997000026A true SV1997000026A (es) 1998-11-10

Family

ID=24521774

Family Applications (1)

Application Number Title Priority Date Filing Date
SV1997000026A SV1997000026A (es) 1996-04-08 1997-04-08 Composiciones farmaceuticas para el tratamiento de la rinitis

Country Status (10)

Country Link
US (2) US6469009B1 (es)
AU (1) AU723364B2 (es)
BR (1) BR9701686A (es)
CO (1) CO4820432A1 (es)
GB (1) GB2311940B (es)
GT (1) GT199700037A (es)
NZ (1) NZ314521A (es)
PA (1) PA8426801A1 (es)
PE (1) PE42598A1 (es)
SV (1) SV1997000026A (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5831066A (en) 1988-12-22 1998-11-03 The Trustees Of The University Of Pennsylvania Regulation of bcl-2 gene expression
IT1303671B1 (it) * 1998-07-28 2001-02-23 Nicox Sa Sali dell'acido nitrico con farmaci attivi nel trattamento dipatologie del sistema respiratorio
US6432961B1 (en) 1998-08-18 2002-08-13 Ucb S.A. Method for preventing the onset of asthma
US6651816B2 (en) * 2001-05-04 2003-11-25 Robert E. Weinstein Antihistamine/decongestant regimens for treating rhinitis
PL206069B1 (pl) * 2001-06-28 2010-06-30 Ucb Farchim Sa Tabletka dwuwarstwowa zawierająca cetyryzynę i pseudoefedrynę
HRP20031057B1 (hr) * 2001-06-28 2013-05-31 Ucb Farchim Sa, Z.I. Planchy Tableta koja sadrži cetirizin i pseudoefedrin
US7403981B2 (en) * 2002-01-04 2008-07-22 Quicksilver Technology, Inc. Apparatus and method for adaptive multimedia reception and transmission in communication environments
CA2478534A1 (en) * 2002-03-13 2003-09-25 Array Biopharma, Inc. N3 alkylated benzimidazole derivatives as mek inhibitors
WO2004000823A1 (en) * 2002-06-21 2003-12-31 Dr. Reddy's Laboratories Limited Amorphous form of(-)-}2-}4-}(4-chlorophenyl)-phenyl methyl}-1-piperazinyl] ethoxy] acetic acid dihydrochloride (levocetririzine dihydrochloride)
WO2004004728A1 (en) * 2002-07-02 2004-01-15 Ucb Farchim S.A. Diarylmethylpiperazines as prophylactic or therapeutic agents for viral myocarditis
JP4303925B2 (ja) * 2002-08-19 2009-07-29 篠田プラズマ株式会社 金属酸化膜の形成方法及びガス放電管の2次電子放出膜形成方法
WO2004052367A1 (en) * 2002-12-06 2004-06-24 Ucb Farchim, S.A. Tablet comprising efletirizine and pseudoephedrine
US20060275516A1 (en) * 2005-06-02 2006-12-07 Ram A N S Compositions and methods for the treatment of allergic rhinitis
US20100172984A1 (en) * 2006-06-06 2010-07-08 Bijay Kumar Padhi tablet dosage form comprising cetirizine and pseudoephedrine
BRPI0713381A2 (pt) 2006-06-28 2012-03-13 Amgen Inc composto, composição farmacêutica, e, método para o tratamento de uma doença
US20080311196A1 (en) * 2006-07-13 2008-12-18 White Donna F All Day Rhinitic Condition Treatment Regimen
US20080015241A1 (en) * 2006-07-13 2008-01-17 Cornerstone Biopharma, Inc. All day rhinitic condition treatment regimen
US20090062305A1 (en) * 2007-08-29 2009-03-05 Protia, Llc Deuterium-enriched cetirizine
US20090082364A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched levocedtirizine
WO2010078541A1 (en) * 2009-01-05 2010-07-08 Mcneil-Ppc, Inc. Tablet containing coated particles of cetirizine, pseudoephedrine, and/or naproxen
CA2748783A1 (en) * 2009-01-05 2010-07-08 Mcneil-Ppc, Inc. Three layer tablet containing cetirizine, pseudoephedrine, and naproxen
US8377475B2 (en) * 2009-01-05 2013-02-19 Mcneil-Ppc, Inc. Tablet containing cetirizine, pseudoephedrine, and naproxen containing a barrier layer

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK154078C (da) * 1981-02-06 1989-05-22 Ucb Sa Analogifremgangsmaade til fremstilling af 2-(2-(4-(diphenyl-methyl)-1-piperazinyl)ethoxy)-acetamider eller syreadditionssalte heraf
US4800162A (en) 1987-04-01 1989-01-24 Sepracor, Inc. Method for resolution of steroisomers in multiphase and extractive membrane reactors
US4829064A (en) 1987-06-08 1989-05-09 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
US5057427A (en) 1988-04-07 1991-10-15 Sepracor, Inc. Method for resolution of stereoisomers
GB8827391D0 (en) 1988-11-23 1988-12-29 Ucb Sa Process for preparation of 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-pipera-zinyl)ethoxy)-acetic acid & its dihydrochloride
US4990535A (en) * 1989-05-03 1991-02-05 Schering Corporation Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
EP0530311A1 (en) * 1990-05-21 1993-03-10 Norwich-Eaton Pharmaceuticals, Inc. The use of phenylpropanolamine as a mucus secretagogue in the upper airways
WO1992004022A1 (en) 1990-09-11 1992-03-19 Richardson Vicks Inc. Use of compositions containing 2-(6'-substituted-2'-naphthyl)-acetic acid derivatives for the treatment of respiratory disorders
WO1994006430A1 (en) 1992-09-24 1994-03-31 Sepracor, Inc. Methods and compositions for treating allergic disorders using optically pure (+) cetirizine
CA2145410A1 (en) 1992-09-24 1994-03-31 Nancy M. Gray Compositions for treating allergic disorders using (-) cetirizine
WO1994008551A2 (en) 1992-10-09 1994-04-28 The Procter & Gamble Company Pharmaceutical compositions and methods for treating cold symptoms
JPH08509725A (ja) 1993-04-30 1996-10-15 ザ、プロクター、エンド、ギャンブル、カンパニー コートされた医薬組成物
CA2170488A1 (en) 1993-09-07 1995-03-16 Sekhar Mitra Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive

Also Published As

Publication number Publication date
MX9702532A (es) 1998-06-30
US6489329B2 (en) 2002-12-03
US6469009B1 (en) 2002-10-22
CO4820432A1 (es) 1999-07-28
GB2311940B (en) 2000-07-19
AU723364B2 (en) 2000-08-24
US20010020023A1 (en) 2001-09-06
GB2311940A (en) 1997-10-15
GB9706842D0 (en) 1997-05-21
AU1774097A (en) 1997-10-16
BR9701686A (pt) 1998-11-10
PA8426801A1 (es) 2000-05-24
GT199700037A (es) 1998-09-26
NZ314521A (en) 1999-09-29
PE42598A1 (es) 1998-08-17

Similar Documents

Publication Publication Date Title
SV1997000026A (es) Composiciones farmaceuticas para el tratamiento de la rinitis
DK0863891T3 (da) (Methylsulfonyl)phenyl-2-(5H)-furanoner som COX2-inhibitorer
UY28674A1 (es) Inhibidores heterociclil amino de 11-beta-hidroxiesteroide deshidrogenasa tipo 1
DK0778834T3 (da) Bicykliske, heterocykliske diarylforbindelser som inhibitorer af cyclooxygenase-2
ES2115237T3 (es) Fenil heterociclos como inhibidores de la ciclooxigenasa-2.
UY25322A1 (es) Compuestos de tiourea y benzamida,composiciones y metodos para tratar y prevenir enfermedades inflamatorias y aterosclerosis
AR012671A1 (es) Composiciones farmaceuticas para el tratamiento o profilaxis de la constipacion, los usos de dichas composiciones y los procesos para prepararlos
NO991494L (no) <beta>-sulfonylhydroksaminsyrer som matriksmetalloproteinaseinhibitorer
DK0828724T3 (da) 5-oxygenerede diaryl-2-(5H)-furanoner som COX-2-inhibitorer
BR0010555A (pt) Inibidores de neuraminidases
CO4920241A1 (es) Compuestos inhibidores de metaloproteasas heterociclicos, composiciones farmaceuticas que los contienen y metodos para su utilizacion
ES2076935T3 (es) Compuesto de pirazolopiridina y procedimientos para su preparacion.
MX9300141A (es) Compuestos de imidazol novedosos, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.
AR008377A1 (es) Un compuesto derivado de la 3-aroilbencilpiridazinona, una composicion farmaceutica particularmente para el tratamiento de enfermedades inflamatorias o autoinmunes que contiene dicho compuesto
DE69426629D1 (de) Therapeutische verbindung - fettsäurekonjugate
ES2196190T3 (es) Inhibidores de metaloproteinasas matriciales, con hidroxamato bifenlico.
AR009358A1 (es) Compuesto espirociclico inhibidor de la metaloproteasa
GT199900015A (es) Procedimiento para tratar la insuficiencia cardiaca
PA8542901A1 (es) Uso de (z)-2-ciano-3-hidroxi-but-2-acido enoico-(4-trifluorometilfenil)-amida para tratar la esclerosis multiple
CO5011084A1 (es) Composiciones y metodos para tratar trastornos respiratorios
ES2123499T3 (es) Metodos y composiciones para tratamiento de infecciones virales.
ES2150461T3 (es) Derivados de amidinofenilalanina, proceso para su preparacion, su empleo y agentes que los contienen como anticoagulantes.
ES2188908T3 (es) Derivados de cis-3,4-cromano utiles para la prevencion o tratamiento de sindromes relacionados con el estrogenos.
HN1997000070A (es) Inhibición de las metaloproteinasas de matriz por acidos 2-((1)-aroilalquil) -4-biaril-4-oxoburiticos
NO983511D0 (no) Difenylstilbener som pro-legemidler for COX-2-inhibitorer

Legal Events

Date Code Title Description
FD Lapse